XCRP (Xcorporeal) Cyclically Adjusted PB Ratio: (As of Aug. 12, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Xcorporeal Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Xcorporeal  (OTCPK:XCRP) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Xcorporeal Cyclically Adjusted PB Ratio Related Terms


Xcorporeal Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Xcorporeal's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xcorporeal Cyclically Adjusted PB Ratio Chart

Xcorporeal Annual Data
Trend Feb99 Feb00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Xcorporeal Quarterly Data
Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

XCRP vs MFST, GTHP, RMSL: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, Xcorporeal's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xcorporeal Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xcorporeal's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Xcorporeal's Cyclically Adjusted PB Ratio falls into.



Xcorporeal Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Xcorporeal's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2009 is calculated as:

For example, Xcorporeal's adjusted Book Value per Share data for the three months ended in Sep. 2009 was:

Adj_Book=Book Value per Share/CPI of Sep. 2009 (Change)*Current CPI (Sep. 2009)
=-0.2/215.9690*215.9690
=-0.200

Current CPI (Sep. 2009) = 215.9690.

Xcorporeal Quarterly Data

Book Value per Share CPI Adj_Book
199911 11.628 168.300 14.921
200002 2.695 169.800 3.428
200005 1.818 171.500 2.289
200008 4.056 172.800 5.069
200012 1.779 174.000 2.208
200103 1.098 176.200 1.346
200106 0.227 178.000 0.275
200109 -0.255 178.300 -0.309
200112 0.663 176.700 0.810
200203 -0.674 178.800 -0.814
200206 -3.008 179.900 -3.611
200209 -3.224 181.000 -3.847
200212 -3.307 180.900 -3.948
200303 -2.847 184.200 -3.338
200306 -2.430 183.700 -2.857
200309 -2.521 185.200 -2.940
200312 -1.306 184.300 -1.530
200403 -1.392 187.400 -1.604
200406 -4.065 189.700 -4.628
200409 -4.139 189.900 -4.707
200412 -5.148 190.300 -5.842
200503 -5.281 193.300 -5.900
200506 -5.451 194.500 -6.053
200509 -5.570 198.800 -6.051
200512 -5.532 196.800 -6.071
200603 -5.834 199.800 -6.306
200606 -5.774 202.900 -6.146
200609 -2.644 202.900 -2.814
200612 24.308 201.800 26.015
200703 -0.021 205.352 -0.022
200706 -0.017 208.352 -0.018
200709 1.284 208.490 1.330
200712 1.061 210.036 1.091
200803 0.751 213.528 0.760
200806 0.444 218.815 0.438
200809 -0.194 218.783 -0.192
200812 -0.138 210.228 -0.142
200903 -0.124 212.709 -0.126
200906 -0.150 215.693 -0.150
200909 -0.200 215.969 -0.200

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Xcorporeal Business Description

Address 80 Empire Drive, Lake Forest, CA, USA, 92630
Xcorporeal Inc is a medical device company, developing an innovative extra-corporeal platform technology to be used in devices to replace the function of various human organs.